Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

Dasatinib

Management of dasatinib-induced pleural effusion at PMID 20375898

X - Pulmonary edema

X.d

Fluid retention

XI - Pulmonary vasculopathies

XI.a

Pulmonary arterial hypertension

XII - Pericardial involvement

XII.b

Pericardial effusion (w/wo tamponade)
XII.g

Pleural/pericardial effusion, ANA positive (DI lupus)
XII.n

Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)

XIV - Pleural involvement

XIV.a

Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV.h

Pleural thickening - Fibrothorax
XIV.n

Chylothorax

XV - Chest pain

XV.a

Chest pain (acute or subacute), lone or prominent
XV.e

Pleuritis (can cause chest pain)

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)
XXIV.i

Progression, acceleration or exacerbation of preexisting ILD/fibrosis
XXIV.j

Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.ad

Pulmonary alveolar proteinosis (PAP)

XXX - Imaging features

XXX.w

Imaging: Interlobular septal thickening
XXX.x

Imaging: Pleural effusion

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.b

Lupus - Lupus syndrome